Unknown

Dataset Information

0

Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.

ABSTRACT:

SUBMITTER: Souza WM 

PROVIDER: S-EPMC8266272 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.

Souza William M WM   Amorim Mariene R MR   Sesti-Costa Renata R   Coimbra Lais D LD   Brunetti Natalia S NS   Toledo-Teixeira Daniel A DA   de Souza Gabriela F GF   Muraro Stefanie P SP   Parise Pierina L PL   Barbosa Priscilla P PP   Bispo-Dos-Santos Karina K   Mofatto Luciana S LS   Simeoni Camila L CL   Claro Ingra M IM   Duarte Adriana S S ASS   Coletti Thais M TM   Zangirolami Audrey B AB   Costa-Lima Carolina C   Gomes Arilson B S P ABSP   Buscaratti Lucas I LI   Sales Flavia C FC   Costa Vitor A VA   Franco Lucas A M LAM   Candido Darlan S DS   Pybus Oliver G OG   de Jesus Jaqueline G JG   Silva Camila A M CAM   Ramundo Mariana S MS   Ferreira Giulia M GM   Pinho Mariana C MC   Souza Leandro M LM   Rocha Esmenia C EC   Andrade Pamela S PS   Crispim Myuki A E MAE   Maktura Grazielle C GC   Manuli Erika R ER   Santos Magnun N N MNN   Camilo Cecilia C CC   Angerami Rodrigo N RN   Moretti Maria L ML   Spilki Fernando R FR   Arns Clarice W CW   Addas-Carvalho Marcelo M   Benites Bruno D BD   Vinolo Marco A R MAR   Mori Marcelo A S MAS   Gaburo Nelson N   Dye Christopher C   Marques-Souza Henrique H   Marques Rafael E RE   Farias Alessandro S AS   Diamond Michael S MS   Faria Nuno R NR   Sabino Ester C EC   Granja Fabiana F   Proença-Módena Jose Luiz JL  

The Lancet. Microbe 20210708 10

<h4>Background</h4>Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response.<h4>Methods</h4>We did an immunological study to assess the n  ...[more]

Similar Datasets

Unknown Weak Cross-Lineage Neutralization by Anti SARS-CoV-2 Spike Antibodies after Natural Infection or Vaccination Is Rescued by Repeated Immunological Stimulation.
| S-EPMC8537215 | biostudies-literature
Unknown Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants.
| S-EPMC10107573 | biostudies-literature
Unknown Neutralisation of ZF2001-elicited antisera to SARS-CoV-2 variants.
| S-EPMC8378832 | biostudies-literature
Unknown Serosurvey in SARS-CoV-2 inactivated vaccine-elicited neutralizing antibodies against authentic SARS-CoV-2 and its viral variants.
| S-EPMC9538410 | biostudies-literature
Unknown Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage.
| S-EPMC9815825 | biostudies-literature
Unknown Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies.
| S-EPMC8645883 | biostudies-literature
Unknown Distinct SARS-CoV-2 antibody reactivity patterns elicited by natural infection and mRNA vaccination.
| S-EPMC8568980 | biostudies-literature
Unknown Kinetics and persistence of anti-SARS-CoV-2 neutralisation and antibodies after BNT162b2 vaccination in a Swiss cohort.
| S-EPMC8926495 | biostudies-literature
Unknown Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies.
| S-EPMC8608826 | biostudies-literature
Unknown SARS-CoV-2 Fusion Peptide-Directed Antibodies Elicited by Natural Infection Mediate Broad Sarbecovirus Neutralization.
| S-EPMC11908342 | biostudies-literature